Armata Pharmaceuticals (ARMP) Return on Capital Employed Growth (1y) (2015 - 2026)
Armata Pharmaceuticals (ARMP) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | -3,457.00 |
| 10 | Armata Pharmaceuticals | 179.00 Mn | 174.20 Mn | - | -22,856.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,856.00 |
| Dec 31, 2025 | 4,692.00 |
| Sep 30, 2025 | -21,697.00 |
| Jun 30, 2025 | -37,745.00 |
| Mar 31, 2025 | -563,141.00 |
| Dec 31, 2024 | -5,036.00 |
| Sep 30, 2024 | 32,676.00 |
| Jun 30, 2024 | 55,013.00 |
| Mar 31, 2024 | 587,955.00 |
| Dec 31, 2023 | 728.00 |
| Sep 30, 2023 | -1,260.00 |
| Jun 30, 2023 | -4,360.00 |
| Mar 31, 2023 | -4,474.00 |
| Dec 31, 2022 | -683.00 |
| Sep 30, 2022 | 2,391.00 |
| Jun 30, 2022 | 2,196.00 |
| Mar 31, 2022 | 2,074.00 |
| Dec 31, 2021 | 1,381.00 |
| Sep 30, 2021 | -1,206.00 |
| Jun 30, 2021 | -338.00 |